Company Filing History:
Years Active: 2015
Title: Takamitsu Kandou: Innovator in Pharmaceutical Crystallization
Introduction
Takamitsu Kandou is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline polymorphs. His work focuses on enhancing the efficacy and stability of pharmaceutical compounds.
Latest Patents
Kandou holds a patent for a compound titled 4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile crystalline polymorph and production method therefor. This invention aims to provide crystal polymorphs of the compound, which is recognized for its pharmaceutical utility. The patent outlines methods for producing three different crystal forms through purification of a corresponding salt, recrystallization, or storage under humidified conditions.
Career Highlights
Kandou is associated with Fuji Yakuhin Co., Ltd., where he applies his expertise in pharmaceutical research and development. His innovative approach has led to advancements in the formulation of pharmaceutical products, contributing to the overall effectiveness of medications.
Collaborations
Kandou has collaborated with notable colleagues such as Yoshiyuki Iwabuchi and Sachiho Miyata. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Takamitsu Kandou's contributions to pharmaceutical crystallization exemplify the importance of innovation in the field. His work not only advances scientific knowledge but also has practical implications for the development of effective medications.